Quantcast

Latest The Oncologist Stories

2014-04-15 23:10:44

A new study published in The Oncologist journal shows that a subset of patients with advanced differentiated thyroid cancer (DTC) and multiple comorbidities in which full-dose sorafenib is considered unsafe can initiate treatment with sorafenib at lower starting doses without adversely affecting efficacy or tolerability compared with full-dose sorafenib. A team of researchers led by Ramona Dadu, MD, at the MD Anderson Cancer Center in Houston, TX, performed a retrospective analysis to...

2014-01-22 23:20:45

A new study published online today in The Oncologist journal shows that an assessment of metabolic response in patients with metastatic colon cancer (mCC) treated with a single course of chemotherapy could predict the downstream efficacy of the treatment. The Engelmann study showed that PET, applied after a single cycle of first-line systemic therapy predicted progression-free survival. Durham, NC (PRWEB) January 22, 2014 A new study published online today in The Oncologist journal shows...

2013-12-05 23:23:04

A recent study featured in the latest issue of The Oncologist shows that active smoking greatly diminishes patients’ chances of responding to chemotherapeutic treatment for renal cell carcinoma (RCC). The research team, jointly led by Dr. Michael Carducci from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD and Dr. Daniel Keizman from the Sackler School of Medicine at Tel Aviv University, conducted a retrospective analysis exploring the association of...

2013-11-20 23:01:29

A new study published online in The Oncologist journal shows that cancer patients with concurrent type 2 diabetes treated with metformin have a greater overall survival rate compared with patients taking other glucose-lowering medications. A team of researchers led by Ming Yin, MD, at Geisinger Medical Center in Danville, PA, performed a meta-analysis to evaluate the association of metformin treatment and both overall and cancer-specific survival. Durham, NC (PRWEB) November 20, 2013 Over...

2013-11-08 23:04:39

A new study just published online in The Oncologist shows that outpatients receiving chemotherapy are at high risk of developing venous thromboembolism (VTE) and of major bleeding complications, especially those with pancreas, stomach and lung cancer. The authors therefore conclude that thromboprophylaxis, or blood thinning treatments, should be considered for such patients, after carefully assessing the risks and benefits of treatment. Durham, NC (PRWEB) November 08, 2013 A large-scale...

2013-10-09 23:01:44

Registration is now open for the Society for Translational Oncology (STO) 2013 Chabner Colloquium: Collaboration in Cancer Trials. The meeting will be held October 28-29, 2013 at the Starr Center at Schepens Eye Research Institute in Boston, Massachusetts. Durham, NC (PRWEB) October 09, 2013 Registration is now open for the Society for Translational Oncology (STO) 2013 Chabner Colloquium: Collaboration in Cancer Trials. The continuing medical education (CME) symposium is jointly sponsored...

2013-09-24 23:00:34

In a recent study published by The Oncologist journal, Professor Ding Ma and colleagues at the Department of Obstetrics and Gynecology, Huazhong University Tongji Medical College have conducted a decade-long, retrospective, multicenter study aimed at clarifying the changing patterns of care and long-term survival rates that have accompanied the shifting demographics of cervical cancer patients in China. Durham, NC (PRWEB) September 24, 2013 Over the last few decades, China, like the...

2013-06-02 23:01:09

To optimize the digital journal experience for cancer physicians, the peer-reviewed journal The Oncologist® has released its newest mobile app. Durham, NC (PRWEB) June 02, 2013 To optimize the digital journal experience for cancer physicians, the peer-reviewed journal The Oncologist® has released its newest mobile app. The fully renewed app is officially launched at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 4. This new app has...

2013-05-30 23:02:21

The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry & Biomedical Sciences, Queen´s University Belfast, Northern Ireland, has been named recipient of the 2013 Bob Pinedo Cancer Care Prize. Durham, NC (PRWEB) May 30, 2013 The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry...

2013-05-28 23:04:09

Treatment with ipilimumab can result in durable antitumor effects despite a low overall response rate in patients with advanced mucosal melanoma (MM). Richard D. Carvajal, MD, Medical Oncologist at the Memorial Sloan-Kettering Cancer Center in New York, led the multicenter, retrospective study, recently published in The Oncologist, in collaboration with researchers from the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston. Durham, NC (PRWEB) May 28, 2013 Treatment...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.